Barometer Capital Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-24,600
Closed -$1.03M – 163
2020
Q2
$1.03M Buy
24,600
+5,600
+29% +$221K 0.19% 98
2020
Q1
$602K Buy
+19,000
New +$727K 0.18% 68
2018
Q4
– Sell
-102,100
Closed -$4.02M – 166
2018
Q3
$4.02M Sell
102,100
-108,800
-52% -$4.13M 0.31% 111
2018
Q2
$7.86M Buy
210,900
+6,500
+3% +$236K 0.66% 48
2018
Q1
$7M Buy
204,400
+128,300
+169% +$4.5M 0.59% 47
2017
Q4
$2.5M Sell
76,100
-8,000
-10% -$250K 0.23% 107
2017
Q3
$2.62M Buy
+84,100
New +$2.47M 0.25% 97

Other funds holding SBIO

Barometer Capital Management's SBIO Position: Q3 2020 in Review

Barometer Capital Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2020, closing a stake of 24,600 shares — an estimated $1.03M sold.

Barometer Capital Management first reported a position in SBIO in Q3 2017 and held it in 7 quarters. The position peaked at $7.86M in Q2 2018. 52 funds tracked by Wall St. Rank hold SBIO as of Q3 2020.

  • Barometer Capital Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2020 after selling out during the quarter.
  • Barometer Capital Management sold 24,600 ALPS Medical Breakthroughs ETF shares in Q3 2020, an estimated $1.03M.
  • Barometer Capital Management first reported a position in ALPS Medical Breakthroughs ETF in Q3 2017 and held it in 7 quarters.
  • Barometer Capital Management's ALPS Medical Breakthroughs ETF position peaked at $7.86M in Q2 2018.
  • 52 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2020.

Based on Barometer Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.